Introducing the Tri-stat, a new Point of Care HbA1c device that offers rapid, precise analysis in a simple and highly cost effective manner. Using boronate affinity technology and a two phase optical system, three samples can be analysed simultaneously and all three results reported in just 10 minutes.

Fast, Easy & Safe

Performance highlights include:

• Up to three samples can be run simultaneously,
• Just 3.5 µl whole blood required (finger stick or venous EDTA/Heparin),
• Minimal operator intervention – simply add sample & run.

The Boronate Affinity Advantage

Boronate affinity technology utilises covalent binding of all cis-diols of glucose to hemoglobin using a boronate matrix. This specific binding allows the complete separation of the glycated and non-glycated haemoglobin fractions.

Overall this provides a patient result with:

• No interference from practically all abnormal hemoglobins,
• Consistent performance with no calibration required,
• The security that glycated haemoglobin is measured accurately every time.

Accurate & Precise

In line with the ADA/EASD/IDF Working Group on HbA1c recent guidelines for reporting HbA1c, the Tri-stat is certified to report in the following units:

• IFCC (mMol HbA1c/mol Hb),
• NGSP (% HbA1c).

Depend on superb precision, linearity & specificity to give reliable, repeatable results for the entire patient population:

• Precision: Intra-run CVs below 3%,
• Linearity: Measurement range of 4 - 14% / 20 - 130 mmol/molHb,
• Specificity: Minimal interference from variants, interferents, matrix effects & sample freezing.